Hui Liu
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Hui Liu has a total of 15 co-authors. Here are the top co-authors by number of shared publications:
- Guobing Yin
Department of Breast and Thyroid Surgery, Second Affiliated Hospital of Chongqing Medical University, Chongqing Medical University, Chongqing, China
2 shared publications - Haojun Luo
Department of Thyroid and Breast Surgery, The Second Affiliated Hospital of Chongqing Medical University, Chongqing, China
2 shared publications - Lu Li
Department of Thyroid and Breast Surgery, The Second Affiliated Hospital of Chongqing Medical University, 74 Linjiang Road, Chongqing, 400010, China, 86 13452999485
2 shared publications - Ao Deng
Department of Thyroid and Breast Surgery, The Second Affiliated Hospital of Chongqing Medical University, 74 Linjiang Road, Chongqing, 400010, China, 86 13452999485
1 shared publication - Haoyu Ren
Department of Thyroid and Breast Surgery, The Second Affiliated Hospital, Chongqing Medical University, Chongqing, China
1 shared publication - Jialun Peng
Department of Hepatobiliary Surgery, The Second Affiliated Hospital of Chongqing Medical University, Chongqing, China
1 shared publication
Latest Publications
- Open Access
- 27 May 2025
- Published by JMIR Publications Inc. in JMIR Medical Informatics
- Vol. 13 (1) , e66429
Large Language Models as a Consulting Hotline for Patients With Breast Cancer and Specialists in China: Cross-Sectional Questionnaire Study
Background: The disease burden of breast cancer is increasing in China. Guiding people to obtain accurate information on breast cancer and improving the public’s health literacy are crucial for the early detection and timely treatment of breast cancer. Large language model (LLM) is a currently popular source of health information. However, the accuracy and practicality of the breast cancer–related information provided by LLMs have not yet been evaluated. Objective: This study aims to evaluate and compare the accuracy, practicality, and generalization-specificity of responses to breast cancer–related questions from two LLMs, ChatGPT and ERNIE Bot (EB). Methods: The questions asked to the LLMs consisted of a patient questionnaire and an expert questionnaire, each containing 15 questions. ChatGPT was queried in both Chinese and English, recorded as ChatGPT-Chinese (ChatGPT-C) and ChatGPT-English (ChatGPT-E) respectively, while EB was queried in Chinese. The accuracy, practicality, and generalization-specificity of each inquiry’s responses were rated by a breast cancer multidisciplinary treatment team using Likert scales. Results: Overall, for both the patient and expert questionnaire, the accuracy and practicality of responses from ChatGPT-E were significantly higher than those from ChatGPT-C and EB (all Ps<.001). However, the responses from all LLMs are relatively generalized, leading to lower accuracy and practicality for the expert questionnaire compared to the patient questionnaire. Additionally, there were issues such as the lack of supporting evidence and potential ethical risks in the responses of LLMs. Conclusions: Currently, compared to other LLMs, ChatGPT-E has demonstrated greater potential for application in educating Chinese patients with breast cancer, and may serve as an effective tool for them to obtain health information. However, for breast cancer specialists, these LLMs are not yet suitable for assisting in clinical diagnosis or treatment activities. Additionally, data security, ethical, and legal risks associated with using LLMs in clinical practice cannot be ignored. In the future, further research is needed to determine the true efficacy of LLMs in clinical scenarios related to breast cancer in China.
- 27 May 2025
- Published by JMIR Publications Inc. in JMIR Medical Informatics
- Vol. 13 (1) , e66429
Open AccessLarge Language Models as a Consulting Hotline for Patients With Breast Cancer and Specialists in China: Cross-Sectional Questionnaire Study
Background: The disease burden of breast cancer is increasing in China. Guiding people to obtain accurate information on breast cancer and improving the public’s health literacy are crucial for the early detection and timely treatment of breast cancer. Large language model (LLM) is a currently popular source of health information. However, the accuracy and practicality of the breast cancer–related information provided by LLMs have not yet been evaluated. Objective: This study aims to evaluate and compare the accuracy, practicality, and generalization-specificity of responses to breast cancer–related questions from two LLMs, ChatGPT and ERNIE Bot (EB). Methods: The questions asked to the LLMs consisted of a patient questionnaire and an expert questionnaire, each containing 15 questions. ChatGPT was queried in both Chinese and English, recorded as ChatGPT-Chinese (ChatGPT-C) and ChatGPT-English (ChatGPT-E) respectively, while EB was queried in Chinese. The accuracy, practicality, and generalization-specificity of each inquiry’s responses were rated by a breast cancer multidisciplinary treatment team using Likert scales. Results: Overall, for both the patient and expert questionnaire, the accuracy and practicality of responses from ChatGPT-E were significantly higher than those from ChatGPT-C and EB (all Ps<.001). However, the responses from all LLMs are relatively generalized, leading to lower accuracy and practicality for the expert questionnaire compared to the patient questionnaire. Additionally, there were issues such as the lack of supporting evidence and potential ethical risks in the responses of LLMs. Conclusions: Currently, compared to other LLMs, ChatGPT-E has demonstrated greater potential for application in educating Chinese patients with breast cancer, and may serve as an effective tool for them to obtain health information. However, for breast cancer specialists, these LLMs are not yet suitable for assisting in clinical diagnosis or treatment activities. Additionally, data security, ethical, and legal risks associated with using LLMs in clinical practice cannot be ignored. In the future, further research is needed to determine the true efficacy of LLMs in clinical scenarios related to breast cancer in China.
- Open Access
- 24 February 2025
- Published by American Association for Cancer Research (AACR) in Cancer Research
- Vol. 85 (8) , 1354-1367
Circulating Tumor Microenvironment in Metastasis
Activation of invasion and metastasis is a central hallmark of cancer, contributing to the primary cause of death for patients with cancer. In the multistep metastatic process, cancer cells must infiltrate the circulation, survive, arrest at capillary beds, extravasate, and form metastatic clones in distant organs. However, only a small proportion of circulating tumor cells (CTC) successfully form metastases, with transit of CTCs in the circulation being the rate-limiting step. The fate of CTCs is influenced by the circulating tumor microenvironment (cTME), which encompasses factors affecting their biological behaviors in the circulation. This liquid and flowing microenvironment differs significantly from the primary TME or the premetastatic niche. This review summarizes the latest advancements in identifying the biophysical cues, key components, and biological roles of the cTME, highlighting the network among biophysical attributes, blood cells, and nonblood factors in cancer metastasis. In addition to the potential of the cTME as a therapeutic target for inhibiting metastasis, the cTME could also represent as a biomarker for predicting patient outcomes and developing strategies for treating cancer.
- 24 February 2025
- Published by American Association for Cancer Research (AACR) in Cancer Research
- Vol. 85 (8) , 1354-1367
Open AccessCirculating Tumor Microenvironment in Metastasis
Activation of invasion and metastasis is a central hallmark of cancer, contributing to the primary cause of death for patients with cancer. In the multistep metastatic process, cancer cells must infiltrate the circulation, survive, arrest at capillary beds, extravasate, and form metastatic clones in distant organs. However, only a small proportion of circulating tumor cells (CTC) successfully form metastases, with transit of CTCs in the circulation being the rate-limiting step. The fate of CTCs is influenced by the circulating tumor microenvironment (cTME), which encompasses factors affecting their biological behaviors in the circulation. This liquid and flowing microenvironment differs significantly from the primary TME or the premetastatic niche. This review summarizes the latest advancements in identifying the biophysical cues, key components, and biological roles of the cTME, highlighting the network among biophysical attributes, blood cells, and nonblood factors in cancer metastasis. In addition to the potential of the cTME as a therapeutic target for inhibiting metastasis, the cTME could also represent as a biomarker for predicting patient outcomes and developing strategies for treating cancer.